Fine Particulate Matter (PM2.5)

Primary sources: Combustion (vehicles, heating, industry), wood-burning, agricultural ammonia.

Health impact: Penetrates deep into lungs and bloodstream. Strongly linked to cardiovascular and respiratory disease, lung cancer, and premature mortality. WHO classifies as Group 1 carcinogen.

Measurement method: Reference: Gravimetric, EN 12341. Equivalent: Beta-attenuation, optical (TEOM, optical particle counter)

Air pollutant concentrations in the European Union are reported under two distinct regulatory regimes that European citizens regularly encounter without realising it. The European Union legal limits, codified in the Ambient Air Quality Directive adopted in 2008 and revised in October 2024, set binding annual and daily ceilings that trigger national action plans and Court of Justice infringement procedures. Separately, the World Health Organization 2021 global air quality guidelines reflect the current epidemiological evidence on cardiovascular, respiratory, and cancer outcomes and operate as a non-binding health benchmark. The gap between the two is the policy lever — the revised 2024 directive halves several legal limits and aligns most thresholds closer to the WHO recommendation by January 2030.

The EU regulatory limit for Fine Particulate Matter (PM2.5) is 2.0× the WHO 2021 health-evidence guideline (10 vs 5ug/m3, both annual means). The revised EU Ambient Air Quality Directive adopted in October 2024 will tighten this gap by 2030.